Market Tracker

09/22 5:16pm ET

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

9.61
Delayed Data
As of Sep 22
 +0.01 / +0.10%
Today’s Change
8.14
Today|||52-Week Range
13.94
-7.51%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close9.60
Today’s open9.60
Day’s range9.60 - 10.01
Volume199,950
Average volume (3 months)152,735
Market cap$385.2M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-200.25%
Earnings growth (this year)+795.83%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-13.04%
P/E ratio16.0
Price/Sales2.86
Price/Book9.40

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc+0.10+1.48%
IOVAIovance Biotherapeut...+0.70+10.00%
TTPHTetraphase Pharmaceu...-0.29-4.24%
DEPODepomed Inc-0.02-0.34%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$149.8M
Annual profit (last year)-$41.2M
Net profit margin-27.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Financial Officer &
Senior Vice President
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts